Mirae Asset Global Investments’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,495
Closed -$320K 1649
2025
Q2
$320K Buy
2,495
+404
+19% +$42K ﹤0.01% 994
2025
Q1
$186K Sell
2,091
-26
-1% -$2.54K ﹤0.01% 1058
2024
Q4
$189K Sell
2,117
-174
-8% -$15.9K ﹤0.01% 1054
2024
Q3
$212K Buy
2,291
+422
+23% +$41.9K ﹤0.01% 1083
2024
Q2
$203K Sell
1,869
-32,663
-95% -$3.27M ﹤0.01% 1046
2024
Q1
$1.72M Sell
34,532
-2,882
-8% -$247K ﹤0.01% 1273
2023
Q4
$3.45M Buy
37,414
+145
+0.4% +$9.39K 0.01% 1028
2023
Q3
$1.87M Buy
37,269
+1,417
+4% +$75.7K ﹤0.01% 1202
2023
Q2
$2.28M Sell
35,852
-1,476
-4% -$80.2K ﹤0.01% 1154
2023
Q1
$1.68M Buy
37,328
+7,090
+23% +$319K ﹤0.01% 1294
2022
Q4
$1.32M Buy
30,238
+63
+0.2% +$3.02K ﹤0.01% 1343
2022
Q3
$1.99M Buy
30,175
+8,935
+42% +$574K 0.01% 1140
2022
Q2
$1.07M Buy
+21,240
New +$1.24M ﹤0.01% 1367
2021
Q4
Sell
-123,042
Closed -$12.7M 1591
2021
Q3
$12.7M Buy
123,042
+24,058
+24% +$2.24M 0.03% 554
2021
Q2
$8.71M Buy
98,984
+32,635
+49% +$2.99M 0.02% 691
2021
Q1
$6.45M Buy
66,349
+28,826
+77% +$2.88M 0.02% 674
2020
Q4
$4.21M Buy
37,523
+6,722
+22% +$708K 0.02% 695
2020
Q3
$2.85M Buy
30,801
+9,731
+46% +$749K 0.01% 686
2020
Q2
$1.64M Buy
21,070
+8,940
+74% +$605K 0.01% 751
2020
Q1
$710K Buy
12,130
+1,193
+11% +$76.8K 0.01% 922
2019
Q4
$876K Buy
10,937
+1,409
+15% +$105K 0.01% 999
2019
Q3
$700K Buy
9,528
+6,120
+180% +$529K ﹤0.01% 1047
2019
Q2
$322K Buy
+3,408
New +$281K ﹤0.01% 1261

Other funds holding BPMC

Mirae Asset Global Investments's BPMC Position: Q3 2025 in Review

Mirae Asset Global Investments sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 2,495 shares — an estimated $320K sold.

Mirae Asset Global Investments first reported a position in BPMC in Q2 2019 and held it in 23 quarters. The position peaked at $12.7M in Q3 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Mirae Asset Global Investments reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,495 Blueprint Medicines shares in Q3 2025, an estimated $320K.
  • Mirae Asset Global Investments first reported a position in Blueprint Medicines in Q2 2019 and held it in 23 quarters.
  • Mirae Asset Global Investments's Blueprint Medicines position peaked at $12.7M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.